ITC's measured playbook: the Indian conglomerate in no hurry to win
Analysis frames ITC's diversified FMCG and consumer businesses as pursuing a deliberate, patient expansion strategy rather than aggressive market grabs. Specifics limited as full article body unavailable.
Analysis piece characterizing ITC, the Indian conglomerate with major FMCG and consumer segments, as taking a measured, unhurried approach across its diversified businesses. Article body not fully available in source.
Why this matters
ITC's patient playbook contrasts with recent volatility: shares dropped 15% in two days on a cigarette excise hike and Nuvama downgrade, even after touching a 52-week high of Rs 327.70.
Retail-company signals are accelerating, up 615400% QoQ.